Quadriceps metabolism during constant workrate cycling exercise in chronic obstructive pulmonary disease

Journal of Applied Physiology

Volumn 110, Issue 1, 2011, Pages 116-124

  Saey, Didier ^a   Lemire, Bruno B ^a   Gagnon, Philippe ^a   Bombardier, Éric ^b   Tupling, A Russell ^b   Debigaré, Richard ^a   Côté, Claude H ^c   Maltais, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Cycle ergometer; Muscle biopsy; Muscle metabolism

Indexed keywords

GLYCOGEN; LACTIC ACID; MUSCLE PROTEIN;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMAN; MALE; METABOLISM; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; SKELETAL MUSCLE; THIGH;

AGED; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; GLYCOGEN; HUMANS; LACTIC ACID; MALE; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SKELETAL; PHYSICAL EXERTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; THIGH;

EID: 79251508705     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00153.2010     Document Type: Article

References (50)

1. Amann M, Dempsey JA. Locomotor muscle fatigue modifies central motor drive in healthy humans and imposes a limitation to exercise performance. J Physiol 586: 161-173, 2008.
2. Amann M, Proctor LT, Sebranek JJ, Pegelow DF, Dempsey JA. Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans. J Physiol 587: 271-283, 2009.
3. Amann M, Regan MS, Kobitary M, Eldridge MW, Boutellier U, Pegelow DF, Dempsey JA. Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD. Am J Physiol Regul Integr Comp Physiol 299: R314-R324, 2010.
4. American Thoracic Society. Standardization of spirometry-1987 update. Official statement of American Thoracic Society. Respir Care 32: 1039-1060, 1987.
5. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36: 936-942, 1982.
6. Bergström J. Muscle electrolytes in man determined by neutron activation analysis on needle biopsy specimens: a study in normal subjects, kidney patients, and patients with chronic diarrhoea. Scand J Clin Lab Invest 14, Suppl 68: 1-110, 1962.
7. Blomstrand E, Celsing F, Friden J, Ekblom B. How to calculate human muscle fibre areas in biopsy samples-methodological considerations. Acta Physiol Scand 122: 545-551, 1984.
8. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14: 377-381, 1982.
9. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 143: 9-18, 1991.
10. CSEP. The Canadian Physical Activity, Fitness, and Lifestyle Approach (CPAFLA) Manual (3rd ed.). Ottawa, ON, Canada: Canadian Society for Exercise Physiology, 2003.
11. Debigaré R, Maltais F. The major limitation to exercise performance in COPD is lower limb muscle dysfunction. J Appl Physiol 105: 751-753, 2008.
12. Fiaccadori E, Del Canale S, Vitali P, Coffrini E, Ronda N, Guariglia A. Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia. Chest 92: 883-887, 1987.
13. Gagnon P, Saey D, Vivodtzev I, Laviolette L, Mainguy V, Milot J, Provencher S, Maltais F. Impact of preinduced quadriceps fatigue on exercise response in chronic obstructive pulmonary disease and healthy subjects. J Appl Physiol 107: 832-840, 2009.
14. Gandevia B, Hugh-Jones P. Terminology for measurements of ventilatory capacity; a report to the thoracic society. Thorax 12: 290-293, 1957.
15. Goldman HI, Becklake MR. Respiratory function tests; normal values at median altitudes and the prediction of normal results. Am Rev Tuberc 79: 457-467, 1959.
16. Gosker HR, van Mameren H, van Dijk PJ, Engelen MP, van der Vusse GJ, Wouters EF, Schols AM. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 19: 617-625, 2002.
17. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 62: 944-949, 2007.
18. Green HJ. Mechanisms of muscle fatigue in intense exercise. J Sports Sci 15: 247-256, 1997.
19. Green HJ, Burnett ME, D'Arsigny CL, O'Donnell DE, Ouyang J, Webb KA. Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease. J Appl Physiol 105: 879-886, 2008.
20. Green HJ, Sutton J, Young P, Cymerman A, Houston CS. Operation Everest II: muscle energetics during maximal exhaustive exercise. J Appl Physiol 66: 142-150, 1989.
21. Harris RC, Hultman E, Nordesjo LO. Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand J Clin Lab Invest 33: 109-120, 1974.
22. Hintz CS, Chi MM, Fell RD, Ivy JL, Kaiser KK, Lowry CV, Lowry OH. Metabolite changes in individual rat muscle fibers during stimulation. Am J Physiol Cell Physiol 242: C218-C228, 1982.
23. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 151: 374-377, 1995.
24. Kelley DE, Slasky BS, Janosky J. Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus. Am J Clin Nutr 54: 509-515, 1991.
25. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 113: 587-600, 1976.
26. Kutsuzawa T, Shioya S, Kurita D, Haida M, Ohta Y, Yamabayashi H. 31P-NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment. Am Rev Respir Dis 146: 1019-1024, 1992.
27. Lowry O, Passonneau J. A Flexible System of Enzymatic Analysis. New York: Academic, 1972.
28. Mabuchi K, Sreter FA. Actomyosin ATPase. II. Fiber typing by histochemical ATPase reaction. Muscle Nerve 3: 233-239, 1980.
29. Maltais F, LeBlanc P, Simard C, Jobin J, Bérubé C, Bruneau J, Carrier L, Belleau R. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154: 442-447, 1996. (Pubitemid 26269117)
30. Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, Bélanger M, Breton MJ, Jobin J. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 55: 848-853, 2000.
31. 2 uptake during exercise in COPD. Med Sci Sports Exerc 33: 916922, 2001.
32. Marquis K, Debigaré R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 809-813, 2002.
33. Noakes TD, St Clair Gibson A, Lambert EV. From catastrophe to complexity: a novel model of integrative central neural regulation of effort and fatigue during exercise in humans: summary and conclusions. Br J Sports Med 39: 120-124, 2005.
34. Pepin V, Saey D, Laviolette L, Maltais F. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation. COPD 4: 195-204, 2007. (Pubitemid 47345896)
35. Pouw EM, Schols AM, van der Vusse GJ, Wouters EF. Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 453-457, 1998.
36. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555, 2007.
37. Rabinovich RA, Vilaro J. Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 16: 123-133, 2010.
38. Richardson RS, Sheldon J, Poole DC, Hopkins SR, Ries AL, Wagner PD. Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159: 881-885, 1999.
39. Saey D, Debigaré R, LeBlanc P, Mador MJ, Côté CH, Jobin J, Maltais F. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168: 425-430, 2003.
40. Saey D, Michaud A, Couillard A, Côté CH, Mador MJ, LeBlanc P, Jobin J, Maltais F. Contractile fatigue, muscle morphometry, and blood lactate in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171: 1109-1115, 2005.
41. Sahlin K. Metabolic factors in fatigue. Sports Med 13: 99-107, 1992.
42. Schreijer AJ, Cannegieter SC, Meijers JC, Middeldorp S, Buller HR, Rosendaal FR. Activation of coagulation system during air travel: a crossover study. Lancet 367: 832-838, 2006.
43. Serres I, Gautier V, Varray A, Préfaut C. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 113: 900-905, 1998.
44. Steiner MC, Evans R, Deacon SJ, Singh SJ, Patel P, Fox J, Greenhaff PL, Morgan MD. Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease. Thorax 60: 932-936, 2005.
45. Thompson CH, Davies RJ, Kemp GJ, Taylor DJ, Radda GK, Rajagopalan B. Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure. Thorax 48: 486-490, 1993. (Pubitemid 23160162)
46. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA. A physical activity questionnaire for the elderly. Med Sci Sports Exerc 23: 974-979, 1991.
47. Westerblad H, Allen DG. Recent advances in the understanding of skeletal muscle fatigue. Curr Opin Rheumatol 14: 648-652, 2002. (Pubitemid 35191550)
48. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, Belleau R, Maltais F. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 30: 1467-1474, 1998.
49. Wuyam B, Payen JF, Levy P, Bensaidane H, Reutenauer H, Le Bas JF, Benabid AL. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J 5: 157-162, 1992.
50. Zammit VA, Newsholme EA. The maximum activities of hexokinase, phosphorylase, phosphofructokinase, glycerol phosphate dehydrogenases, lactate dehydrogenase, octopine dehydrogenase, phosphoenolpyruvate carboxykinase, nucleoside diphosphatekinase, glutamate-oxaloacetate transaminase and arginine kinase in relation to carbohydrate utilization in muscles from marine invertebrates. Biochem J 160: 447-462, 1976.